DK1509241T3 - New uses of cephaiboles - Google Patents

New uses of cephaiboles

Info

Publication number
DK1509241T3
DK1509241T3 DK03722587T DK03722587T DK1509241T3 DK 1509241 T3 DK1509241 T3 DK 1509241T3 DK 03722587 T DK03722587 T DK 03722587T DK 03722587 T DK03722587 T DK 03722587T DK 1509241 T3 DK1509241 T3 DK 1509241T3
Authority
DK
Denmark
Prior art keywords
aib
hyp
iva
gln
phe
Prior art date
Application number
DK03722587T
Other languages
Danish (da)
Inventor
Brigitte Schlegel
Albert Haertl
Udo Graefe
Matthias Schiell
Laszlo Vertesy
Joachim Wink
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1509241T3 publication Critical patent/DK1509241T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Use of cephaibiol peptides (A) or their salts to prepare compositions with neurological and/or immunosuppressive activity. Use of cephaibiol peptides (A) or their salts, of formulae (I) or (II) to prepare compositions with neurological and/or immunosuppressive activity AcPhe-(Aib) 3-x-w-Leu-y-Aib-Hyp-Gln-z-Hyp-Aib-Pro-R (I) AcPhe-Iva-Gln-Aib-Ile-Thr-Aib-Leu-Aib-x-Gln-Aib-Hyp-Aib-Pro-Phe-Ser (II) Aib : alpha -aminobutyric acid; Iva : isovaline; Hyp : hydroxyproline; R : Phe-ol (phenylalaninol) or Phe-al (phenylalaninal); in (I), w : Gly or Ala, x = Aib and y = z = Iva, or w = Gly and then x, y and z = all Iva or all Aib, or x and one of y and z = Aib and the other is Iva; in (II), x : Hyp or Pro ACTIVITY : Neuroleptic; Immunosuppressive; Tranquilizer; Antimanic; Nephrotropic; Antiinflammatory; Hepatotropic; Antirheumatic; Analgesic; Antiemetic. Test methods for these activities are described but no results are given. MECHANISM OF ACTION : None given.
DK03722587T 2002-05-23 2003-05-02 New uses of cephaiboles DK1509241T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10222792A DE10222792A1 (en) 2002-05-23 2002-05-23 New use of cephaiboles

Publications (1)

Publication Number Publication Date
DK1509241T3 true DK1509241T3 (en) 2007-01-15

Family

ID=29414050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03722587T DK1509241T3 (en) 2002-05-23 2003-05-02 New uses of cephaiboles

Country Status (12)

Country Link
EP (2) EP1509241B1 (en)
JP (1) JP2005528421A (en)
AT (1) ATE336259T1 (en)
AU (1) AU2003229766A1 (en)
BR (1) BR0311238A (en)
CA (1) CA2487246A1 (en)
DE (2) DE10222792A1 (en)
DK (1) DK1509241T3 (en)
ES (1) ES2271575T3 (en)
MX (1) MXPA04011130A (en)
PT (1) PT1509241E (en)
WO (1) WO2003099317A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19740030A1 (en) * 1997-09-11 1999-03-18 Knoell Hans Forschung Ev Ampullosporin, process for its preparation and its use
DE19920816A1 (en) * 1999-05-05 2000-11-09 Aventis Pharma Gmbh Cephaibole, new antiparasitic drugs from Acremonium tubakii, process for their manufacture and use thereof
DE19948644A1 (en) * 1999-10-01 2001-04-05 Knoell Hans Forschung Ev New peptaibol peptides produced by Sepedonium fungus, useful as antibacterial, antifungal, neuroleptic and anxiolytic agents

Also Published As

Publication number Publication date
PT1509241E (en) 2007-01-31
BR0311238A (en) 2005-03-15
JP2005528421A (en) 2005-09-22
CA2487246A1 (en) 2003-12-04
EP1679081A2 (en) 2006-07-12
MXPA04011130A (en) 2005-08-15
EP1509241A1 (en) 2005-03-02
EP1509241B1 (en) 2006-08-16
WO2003099317A1 (en) 2003-12-04
ATE336259T1 (en) 2006-09-15
DE50304667D1 (en) 2006-09-28
DE10222792A1 (en) 2003-12-04
ES2271575T3 (en) 2007-04-16
EP1679081A3 (en) 2006-08-02
AU2003229766A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
PE20080339A1 (en) MODIFIED POLYPEPTIDES OF THE COAGULATION FACTOR IX AND USE OF THE SAME FOR TREATMENT
JP2005528401A5 (en)
ES2721172T3 (en) A new class of protein-based therapeutic molecules
CY1108137T1 (en) COMPOSITION FOR DOSAGE INHALATOR INHIBITOR USING HYDRO-FLUOR-ALKANIA AS PROMOTIONAL
RU2008136324A (en) GASTROINTESTINAL PROLIFERATIVE FACTOR AND ITS APPLICATIONS
PT99068B (en) PROCESS FOR THE PREPARATION OF TRIPEPTIDIC ANTITROMBOTIC AGENTS
NO20050537L (en) Use of HMGB1 in the treatment of tissue damage and / or to promote tissue repair
ES2160485B1 (en) INHIBITING PEPTIDES OF NEURONAL EXOCITOSIS, COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2421447T3 (en) Methods to protect against apoptosis using lipopeptides
ES2125225T3 (en) PEPTIDE AMIDES, PROCEDURE FOR THE PREPARATION AND AGENTS CONTAINING THEM AS INHIBITORS OF FIBRIN / THROMBIN COAGULATION.
PT95582B (en) METHOD FOR PREPARING ANTAGONISTIC PEPTIDIC COMPOUNDS OF THE FIBRINOGENIC RECEPTOR
CO6260099A2 (en) CYCLE DEPSIPEPTIDES
CO5680457A2 (en) NOGO-A UNION MOLECULES AND PHARMACEUTICAL USE OF THE SAME
BR0116122A (en) Peptides and / or proteins as well as their use to prepare a pharmaceutical, therapeutic and / or preventative composition.
DE50105373D1 (en) DIPEPTIDIC INGREDIENTS FOR COOLING FACTOR XA
BRPI0302496C1 (en) pharmaceutical compositions with antibiotic activity
DK1509241T3 (en) New uses of cephaiboles
FR2846883B1 (en) COSMETIC COMPOSITION COMPRISING, AS ACTIVE INGREDIENT, AT LEAST ONE PEPTIDE AND USE OF THIS PEPTIDE
FR2915397B1 (en) PHARMACEUTICAL AND / OR COSMETIC COMPOSITION CONTAINING ACTIVE ACONITASE ACTIVATOR PRINCIPLES
DE60031422D1 (en) PEPTIDE ANALOGUE AS SELECTIVE INHIBITORS OF THROMBINACTIVATION OF THE PROTEASE-ACTIVATED RECEPTOR
ATE474589T1 (en) ANGIOGENIC PEPTIDES AND THEIR USES
EA200501557A1 (en) NEW METHOD OF SYNTHESIS (2S) -INDOLIN-2-CARBONIC ACID AND USE IN PERINDOPRIL SYNTHESIS
EA200300483A1 (en) INHALATION COMPOSITION IN THE FORM OF SOLUTION WITH TIOTROPY SALT
ATE510008T1 (en) ANTI-INFLAMMATORY PEPTIDES
RU2010130763A (en) METHODS AND PHARMACOLOGICAL COMPOSITIONS FOR HEALING RAS